PerCP/Cyanine5.5 anti-human CD183 (CXCR3) 353714 from BioLegend

Product Specs
ItemPerCP/Cyanine5.5 anti-human CD183 (CXCR3)
CompanyBioLegend
Price Pricing Info Supplier Page View Company Product Page
Catalog Number353714
ReactivityHuman, Cynomolgus, Rhesus
HostMouse
IsotypeIgG1, Kappa
NCBI Gene AliasesCD182, CD183, CKR-L2, CMKAR3, GPR9, IP10-R, Mig-R, MigR
Conjugate/TagPERCP_CYANINE5.5
CloneG025H7
Quantity100 tests
ApplicationsFlow Cytometry (FC)
Antibody TypePrimary
NCBI Full Gene NameC-X-C motif chemokine receptor 3
FormatPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
ImmunogenHuman CXCR3 transfectants
ClonalityMonoclonal
TargetCD183

Add to Compare List

BioLegend

8999 BioLegend Way

San Diego, California 92121

United States

Phone: 1-877-246-5343 Toll-Free, USA & Canada
1-858-768-5800 International
Fax: 1-877-455-9587

Company Profile

Website: biolegend.com

(1) Prolonged T-cell activation and long COVID symptoms independently associate with severe COVID-19 at 3 monthseLifeJune 13, 2023Marianna Santopaolo, Michaela Gregorova, Fergus Hamilton, David Arnold, Anna Long, Aurora Lacey, Elizabeth Oliver, Alice Halliday, Holly Baum, Kristy Hamilton, et al.(FN50),Biolegend,Cat# 310931,FC (5:50) Antibody,Mouse monoclonal anti-human CXCR3 (G025H7),Biolegend,Cat# 353714,FC (1:50) Antibody,Mouse monoclonal anti-human CD45RA (HI100),BD Biosciences,Cat# 561882,FC (10:50) Antibody,Mouse

(2) Targeted plasma proteomics reveals upregulation of distinct inflammatory pathways in people living with HIViScienceOctober 21, 2022Nadira Vadaq, Lisa van de Wijer, Louise E. van Eekeren, Hans Koenen, Quirijn de Mast, Leo A.B. Joosten, Mihai G. Netea, Vasiliki Matzaraki, André J.A.M. van der VenECD, SFCI21Thy",Beckman Coulter,Cat#737659; RRID: AB_2751015 "CD183 PerCp5.5, G025H7",Biolegend,Cat#353714; RRID: AB_10962908 "CD194 PC7,1G1",BD,Cat#557864; RRID: AB_396907 "CD25 APC, 2A3",BD,Cat#340907; RRID:

(3) Clusters of Tolerogenic B Cells Feature in the Dynamic Immunological Landscape of the Pregnant UterusCell reportsSeptember 29, 2020Benner M, Feyaerts D, García CC, Inci N, López SC, Fasse E, Shadmanfar W, van der Heijden OWH, Gorris MAJ, Joosten I, et al.

(4) Fatty Acid Metabolites Combine with Reduced β Oxidation to Activate Th17 Inflammation in Human Type 2 DiabetesCell metabolismSeptember 3, 2019Nicholas DA, Proctor EA, Agrawal M, Belkina AC, Van Nostrand SC, Panneerseelan-Bharath L, Jones AR 4th, Raval F, Ip BC, Zhu M, et al.

(5) A validated single-cell-based strategy to identify diagnostic and therapeutic targets in complex diseasesGenome medicineJuly 30, 2019Gawel DR, Serra-Musach J, Lilja S, Aagesen J, Arenas A, Asking B, Bengnér M, Björkander J, Biggs S, Ernerudh J, et al.USA; cat. no. 561028), anti-human CD183 (CXCR3)-PerCP/Cy5.5 (Biolegend, San Diego, CA, USA; cat. no. 353713), anti-human CD196 (CCR6)-PE/Cy7 (Biolegend, San Diego, CA, USA; cat. no. 353417), anti-human CD45RA-APC

(6) Disruption of an antimycobacterial circuit between dendritic and helper T cells in human SPPL2a deficiencyNature immunologySeptember 1, 2018Kong XF, Martinez-Barricarte R, Kennedy J, Mele F, Lazarov T, Deenick EK, Ma CS, Breton G, Lucero KB, Langlais D, et al.Biolegend) BV421, anti-CD25 (564033, 2A3, BD) PE-Cy7, anti-CXCR5 (558113, RF8B2), BD) A647, anti-CXCR3 (353713, Go25H7, BioLegend) PerCP-Cy5.5 and anti-CCR6 (559562, 11A9, BD) PE and the proportions of regulatory T cells

(7) A human anti-IL-2 antibody that potentiates regulatory T cells by a structure-based mechanismNature medicineJuly 1, 2018Trotta E, Bessette PH, Silveria SL, Ely LK, Jude KM, Le DT, Holst CR, Coyle A, Potempa M, Lanier LL, et al.BD Biosciences, no. 555801, lot no. 3303846, 1:25), CXCR3 PerCp-Cy5.5 (clone G025H7, Biolegend, no. 353714, lot no. B186023, 1:50), CCR6 PE-Cy7 (clone 11A9, BD Biosciences, no. 560620, lot no. 7117549, 1:25),

(8) Natural cytotoxicity receptor splice variants orchestrate the distinct functions of human natural killer cell subtypesNature communicationsDecember 15, 2015Siewiera J, Gouilly J, Hocine HR, Cartron G, Levy C, Al-Daccak R, Jabrane-Ferrat N.

(9) Phase Ia Study of FoxP3+ CD4 Treg Depletion by Infusion of a Humanized Anti-CCR4 Antibody, KW-0761, in Cancer PatientsClinical cancer research : an official journal of the American Association for Cancer ResearchOctober 1, 2015Kurose K, Ohue Y, Wada H, Iida S, Ishida T, Kojima T, Doi T, Suzuki S, Isobe M, Funakoshi T, et al.

(10) Divergent Phenotypes of Human Regulatory T Cells Expressing the Receptors TIGIT and CD226Journal of immunology (Baltimore, Md. : 1950)July 1, 2015Fuhrman CA, Yeh WI, Seay HR, Saikumar Lakshmi P, Chopra G, Zhang L, Perry DJ, McClymont SA, Yadav M, Lopez MC, et al.

(11) Prolongation of overall survival in advanced lung adenocarcinoma patients with the XAGE1 (GAGED2a) antibodyClinical cancer research : an official journal of the American Association for Cancer ResearchOctober 1, 2014Ohue Y, Kurose K, Mizote Y, Matsumoto H, Nishio Y, Isobe M, Fukuda M, Uenaka A, Oka M, Nakayama E.

(12) An interfering factor in the automated analysis of calciumJournal of clinical pathologyFebruary 1, 1979P Gosling, H G Sammons

Write a Review

(1)

5/23/2017Analysis Of CD8+ CD183+ Cell Population And Its Potential As T Regulatory Cells Anirban BanerjeeCD183 or CXCR3 is a Gai protein-coupled chemokine receptor and is generally related to leukocyte migration and trafficking when expressed on Th1 cells. It may also be expressed upon T effectors as ... Read Review
(1)

11/6/2015CXCR3 in Human T cells Jesus BanuelosThe aim of the research was to determine the percent of CD4+CXCR3+ T cells from human peripheral blood.

PerCP/Cyanine5.5 anti-human CD183 (CXCR3) from BioLegend

Description

BioLegend

Citations (12)

Reviews

PerCP/Cyanine5.5 anti-human CD183 (CXCR3) from BioLegend

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map